Anti-GalNAc-GD1a Monoclonal Antibody (2A3D2)1vial

4-Oxoadamantane-1-carboxylic acid, 95.0%, 500g

4-Propylphenylboronic acid, 97.0%, 5g

2-Methyl-2,6-diazaspiro[3.4]octane dihydrochloride, 95%, 100mg

3,3,3-Trifluoropropionyl chloride, 98.0%, 1g

1-Propanamine, N,N-dimethyl-2,3-bis[(9Z)-9-octadecenyloxy]-, 97%, 100mg

N-(4-methoxybenzyl)glycine, 95.0%, 250mg

Prop-2-ene-1-sulfonyl chloride, 95.0%, 250mg

2,6-Difluoro-3-iodoanisole, 98%, 10g

4-Bromo-3,5-dimethyl-1-(propan-2-yl)-1h-pyrazole, 98%, 1g

(+/-)-2-(Aminomethyl)-1-N-Boc-pyrrolidine, 98.0%, 25g

ethyl 2-methylquinoline-3-carboxylate, 95.0%, 1g

Oxazine 720 perchlorate, min. 96%, 1 g, glass packaging